PracticeVideosBlogFlashcardsEspañol
All Practice Exams

100+ Free Facharzt FMH Gynäkologie und Geburtshilfe Practice Questions

Prepare for the Facharzt FMH für Gynäkologie und Geburtshilfe / Spécialiste FMH en gynécologie et obstétrique exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
100+ Questions
100% Free

Loading practice questions...

Same family resources

Explore More Swiss FMH Medical Specialist Examinations (Facharzt SIWF/FMH)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Facharzt FMH Allgemeine Innere Medizin (Switzerland)

Practice Questions

Facharzt FMH Anästhesiologie (Switzerland)

Practice Questions

Facharzt FMH Chirurgie (Switzerland)

Practice Questions

Facharzt FMH Dermatologie und Venerologie (Switzerland)

Practice Questions

Facharzt FMH Hals-Nasen-Ohren (Otorhinolaryngologie) (Switzerland)

Practice Questions

Facharzt FMH Intensivmedizin (Switzerland)

Practice Questions
2026 Statistics

Key Facts: Facharzt FMH Gynäkologie und Geburtshilfe Exam

SGGG / SSGO

Exam Body

SIWF / SGGG Examination Regulations

120

Written Exam MCQs

SGGG Examination Committee

5 Years

Postgraduate Training

SIWF Weiterbildungsprogramm

240 min

Written Duration

SGGG Examination Regulations

Lifetime

FMH Title Validity

Swiss Medical Association (FMH)

100

Practice Questions

OpenExamPrep

The Facharzt FMH Gynäkologie und Geburtshilfe credential certifies specialist obstetricians and gynecologists in Switzerland through SIWF and SGGG. Assessment comprises a 120-MCQ written examination (Basisexamen/Schlussexamen Teil 1) and a structured oral-practical examination (Schlussexamen Teil 2) covering obstetrics, general gynecology, oncology, endocrinology, and urogynecology.

Sample Facharzt FMH Gynäkologie und Geburtshilfe Practice Questions

Try these sample questions to test your Facharzt FMH Gynäkologie und Geburtshilfe exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 29-year-old primigravida at 34+2 weeks of gestation presents to the labor ward with a severe throbbing frontal headache, visual scotoma, and epigastric discomfort. Her blood pressure is 168/112 mmHg on two measurements taken 15 minutes apart. Urinalysis shows 3+ proteinuria (protein-to-creatinine ratio 0.8 mg/mg). Laboratory analysis reveals platelet count 145,000/µL, serum creatinine 75 µmol/L, AST 38 U/L, and LDH 210 U/L. Fetal cardiotocography (CTG) is reassuring with a normal baseline of 135 bpm. In accordance with SGGG and international guidelines, what is the most urgent and appropriate initial pharmacotherapy regimen?
A.Intravenous magnesium sulfate loading dose (4–6 g over 20 minutes) plus intravenous labetalol (or oral rapid-acting nifedipine) for acute blood pressure lowering
B.Immediate intravenous hydralazine bolus alone without magnesium sulfate, withholding seizure prophylaxis unless hyperreflexia is documented
C.Oral diazepam 10 mg for seizure prophylaxis combined with oral furosemide 40 mg for diuresis
D.Immediate urgent cesarean delivery under general anesthesia prior to initiating maternal blood pressure stabilization
Explanation: This patient presents with preeclampsia with severe features (severe hypertension ≥160/110 mmHg and end-organ neurological/epigastric symptoms). First-line immediate management consists of parenteral magnesium sulfate (4–6 g IV loading dose followed by 1–2 g/h maintenance) to prevent eclamptic seizures (Magpie Trial) and urgent antihypertensive therapy (intravenous labetalol or oral rapid-release nifedipine) to achieve a target blood pressure of 135–150/85–100 mmHg and prevent maternal hemorrhagic stroke.
2A 32-year-old woman at 30+4 weeks of gestation in her first pregnancy is being monitored for early-onset fetal growth restriction (FGR). Fetal biometry shows an estimated fetal weight at the 2nd percentile. Umbilical artery (UA) Doppler ultrasound reveals absent end-diastolic flow (AEDF). Middle cerebral artery (MCA) Doppler demonstrates brain-sparing with a pulsatility index (PI) below the 5th percentile. Ductus venosus (DV) Doppler shows forward flow during atrial systole (positive a-wave). Computerized cardiotocography (cCTG) shows a short-term variability (STV) of 4.2 ms with no decelerations. According to ISUOG and TRUFFLE consensus guidelines, what is the most appropriate management plan?
A.Immediate emergency cesarean section within 2 hours without awaiting corticosteroid maturation
B.Administer antenatal corticosteroids (betamethasone 12 mg IM, two doses 24 hours apart), hospitalize for daily cCTG and DV Doppler monitoring, aiming for delivery if DV a-wave becomes absent/reversed or cCTG STV drops <3.5 ms
C.Outpatient weekly ultrasound surveillance with no indication for maternal corticosteroids since ductus venosus flow remains normal
D.Immediate labor induction with vaginal misoprostol after administration of maternal intravenous hydration
Explanation: In early-onset FGR at 30 weeks with umbilical artery absent end-diastolic velocity (AEDF) but preserved ductus venosus forward flow (normal a-wave) and reassuring cCTG (STV >3.5 ms), immediate delivery is not mandated. The randomized TRUFFLE study demonstrated that timing delivery based on ductus venosus abnormalities or abnormal cCTG STV optimizes long-term neurodevelopmental outcomes while avoiding unnecessary iatrogenic extreme prematurity. Antenatal corticosteroids should be completed, with close inpatient surveillance (daily cCTG and DV Doppler).
3A 28-year-old woman with a monochorionic diamniotic (MCDA) twin pregnancy presents at 19+4 weeks for routine ultrasound. The inter-twin membrane is confirmed. Twin A exhibits a deepest vertical pocket (DVP) of amniotic fluid of 1.5 cm with a non-visualized collapsed bladder. Twin B exhibits a DVP of 9.2 cm with a significantly distended bladder. Umbilical artery Doppler in Twin A demonstrates persistent absent end-diastolic flow, while Twin B has normal Doppler waveforms. According to the Quintero staging system and SGGG/ISUOG guidelines, what stage is this condition and what is the primary gold standard intervention?
A.Quintero Stage I; managed expectantly with serial weekly ultrasound surveillance
B.Quintero Stage II; treated primarily with serial aggressive amnioreduction of the recipient twin's sac
C.Quintero Stage III; treated with fetoscopic laser photocoagulation of communicating placental anastomoses (Solomon technique)
D.Quintero Stage IV; managed with selective feticide of Twin A via cord occlusion
Explanation: This case represents Twin-to-Twin Transfusion Syndrome (TTTS) Quintero Stage III. Stage I is oligohydramnios/polyhydramnios sequence (DVP <2 cm in donor, >8 cm in recipient); Stage II is non-visualization of the donor bladder; Stage III is characterized by critically abnormal Doppler flows (absent/reversed umbilical artery end-diastolic flow, reversed ductus venosus a-wave, or umbilical vein pulsatility). Fetoscopic laser photocoagulation of all placental vascular anastomoses along the vascular equator (the Solomon technique) is the gold standard treatment between 16 and 26 weeks, significantly superior to amnioreduction in survival and neurological outcomes.
4A 31-year-old P2G2 woman delivers a 4,100 g infant vaginally following a 10-hour labor augmented with oxytocin. Ten minutes after delivery of the placenta, brisk vaginal bleeding is noted, totaling approximately 800 mL within 5 minutes. On abdominal palpation, the uterine fundus is soft, boggy, and located 3 cm above the umbilicus. Continuous uterine massage is initiated. What is the most appropriate next pharmacotherapy step according to SGGG postpartum hemorrhage (PPH) guidelines?
A.Administer oral methylergometrine 0.2 mg and await response before giving parenteral agents
B.Administer intramuscular carboprost tromethamine (15-methyl PGF2alpha) 250 µg as the sole first-line agent
C.Administer intravenous recombinant factor VIIa immediately as first-line hemostatic therapy
D.Administer intravenous oxytocin (bolus of 5–10 IU slowly or infusion of 20–40 IU in 500 mL saline) plus intravenous tranexamic acid 1 g within 3 hours of birth
Explanation: Primary postpartum hemorrhage caused by uterine atony (the most common cause, >70%) requires immediate active management: fundal massage, first-line uterotonic therapy with intravenous oxytocin (5–10 IU slow IV bolus and/or infusion of 20–40 IU/L), and prompt administration of intravenous tranexamic acid (1 g over 10 minutes). Landmark evidence from the WOMAN trial confirmed that early administration of tranexamic acid within 3 hours of delivery significantly reduces maternal death due to bleeding without increasing thromboembolic risk.
5A 26-year-old primigravida at 31+1 weeks of gestation presents with sudden painless pooling of clear fluid from the vagina. Sterile speculum examination confirms clear amniotic fluid pooling in the posterior fornix with positive IGFBP-1 / PAMG-1 rapid test. Maternal temperature is 36.8°C, maternal pulse 76 bpm, and fetal heart rate is 140 bpm with no uterine contractions. Laboratory markers (CRP and leukocyte count) are normal. What is the standard evidence-based management strategy for this patient with preterm premature rupture of membranes (PPROM)?
A.Immediate labor induction with vaginal dinoprostone to prevent intrauterine infection
B.Hospital admission, administration of antenatal corticosteroids (betamethasone), latency antibiotic therapy (oral erythromycin or IV ampicillin followed by oral amoxicillin), and expectant management with maternal/fetal surveillance until 34–37 weeks
C.Immediate placement of an emergency rescue cervical cerclage to prevent further amniotic leakage
D.Continuous tocolytic therapy with intravenous atosiban for 14 consecutive days until reaching 34 weeks of gestation
Explanation: For preterm PROM between 24 and 34 weeks of gestation without evidence of chorioamnionitis or fetal compromise, expectant management is standard of care. This comprises: 1) Antenatal corticosteroids (e.g., betamethasone 12 mg IM q24h x 2 doses) for fetal lung and brain maturation; 2) Latency antibiotics (e.g., oral erythromycin or ampicillin/amoxicillin for 7–10 days) which prolong latency, reduce neonatal sepsis, and decrease intraventricular hemorrhage (ORACLE I trial); 3) Magnesium sulfate for neuroprotection if delivery is imminent before 32 weeks; 4) Surveillance for chorioamnionitis and planned delivery at 34–37 weeks.
6During a vaginal delivery of a 4,350 g infant in a diabetic mother at 39 weeks, the fetal head delivers easily over the perineum, but immediately retracts against the maternal vulva ('turtle sign'). Gentle axial traction fails to deliver the anterior shoulder. The obstetric team declares a shoulder dystocia. According to standard obstetric algorithms (HELPERR), what is the correct initial sequence of physical maneuvers?
A.Apply vigorous fundal pressure while pulling the fetal head downward at a 45-degree angle
B.Perform immediate Zavanelli cephalic replacement maneuver followed by emergency cesarean section
C.Hyperflex the maternal thighs sharply against the abdomen (McRoberts maneuver) while an assistant applies directed suprapubic pressure
D.Perform an intentional clavicular fracture on the anterior fetal shoulder before repositioning the mother
Explanation: The initial first-line management of shoulder dystocia (HELPERR algorithm) consists of calling for help, avoiding fundal pressure, performing the McRoberts maneuver (hyperflexion and abduction of the maternal hips, which flattens the sacral promontory and rotates the symphysis pubis cephalad), and applying simultaneous suprapubic pressure (Rubin I maneuver) to disimpact the anterior shoulder. These two maneuvers resolve over 50–70% of shoulder dystocias without fetal trauma.
7A 27-year-old G1P0 woman at 40+1 weeks is in active labor at 6 cm cervical dilation. The intrapartum cardiotocogram (CTG) demonstrates a baseline fetal heart rate of 145 bpm, baseline variability of 2 bpm (persistently <5 bpm for >50 minutes), and recurrent U-shaped decelerations starting after the peak of each uterine contraction and returning to baseline well after the contraction ends. According to FIGO 2015 and SGGG intrapartum monitoring guidelines, how is this CTG categorized and what is the required clinical action?
A.Normal CTG; continue routine labor surveillance without intervention
B.Suspicious CTG; perform a vibroacoustic stimulation test and reassess in 2 hours
C.Normal physiological response to head compression (early decelerations); encourage maternal pushing
D.Pathological (abnormal) CTG; initiate intrauterine resuscitation (maternal repositioning, stop oxytocin, IV fluids, rule out hypotension/tachysystole) and prepare for rapid operative delivery if not rapidly resolving
Explanation: The presence of reduced baseline variability (<5 bpm for >50 minutes) combined with recurrent late decelerations (gradual decrease and return of fetal heart rate after the contraction peak) defines a Pathological (Abnormal) CTG under FIGO 2015 guidelines. Late decelerations reflect uteroplacental insufficiency and fetal hypoxia/acidosis. Immediate intrauterine resuscitation is required: lateral maternal repositioning, discontinuation of oxytocin infusion, IV fluid bolus, tocolysis with beta-mimetics if uterine tachysystole is present, and immediate delivery if resuscitation fails.
8A 33-year-old primigravida at 38 weeks of gestation presents in active labor with spontaneous rupture of membranes. Her routine rectovaginal culture performed at 36 weeks was positive for Group B Streptococcus (GBS / Streptococcus agalactiae). She reports a mild childhood rash following oral amoxicillin, but has never experienced urticaria, respiratory distress, or anaphylaxis. According to SGGG and CDC guidelines, what is the optimal intrapartum antibiotic prophylaxis (IAP) regimen?
A.Intravenous Cefazolin (2 g loading dose, followed by 1 g every 8 hours until delivery)
B.Intravenous Clindamycin 900 mg every 8 hours without checking susceptibility testing
C.Intravenous Vancomycin 1 g every 12 hours as standard first-line therapy for any reported penicillin allergy
D.Oral Erythromycin 500 mg every 6 hours throughout active labor
Explanation: Universal screening for GBS at 35–37 weeks identifies colonized women who require intrapartum antibiotic prophylaxis (IAP) to prevent early-onset neonatal GBS sepsis. While IV Penicillin G (or Ampicillin) is the first-line choice for non-allergic patients, Cefazolin (2 g loading, then 1 g q8h) is the preferred first-line agent in patients with a history of penicillin allergy who are at LOW risk of anaphylaxis (e.g., maculopapular rash without systemic/IgE-mediated symptoms). Cefazolin achieves high amniotic and fetal tissue concentrations.
9A 30-year-old pregnant woman following in vitro fertilization (IVF) has an ultrasound at 22 weeks showing a bilobed placenta with a succenturiate lobe. Transvaginal color Doppler ultrasound demonstrates fetal blood vessels crossing the internal cervical os, unsupported by placental tissue or Wharton's jelly, located 1.2 cm above the internal os. The patient remains completely asymptomatic with closed cervix. What is the diagnosis and the recommended management plan to ensure optimal perinatal survival?
A.Placenta previa marginalis; allow trial of spontaneous vaginal delivery with continuous electronic fetal monitoring at term
B.Placenta accreta; schedule emergency cesarean hysterectomy at 28 weeks
C.Vasa previa; schedule an elective cesarean delivery prior to the onset of labor and membrane rupture (typically at 34+0 to 36+0 weeks) following antenatal corticosteroids
D.Velamentous cord insertion without clinical significance; no modification of standard obstetric care is required
Explanation: Vasa previa occurs when fetal blood vessels traverse the fetal membranes across the lower uterine segment covering or within 2 cm of the internal cervical os, ahead of the presenting part. Rupture of membranes can tear these fetal vessels (yielding fetal exsanguination with >50–60% perinatal mortality if undiagnosed). When diagnosed prenatally, planned elective cesarean delivery at 34+0 to 36+0 weeks (after antenatal corticosteroids) results in >95% intact perinatal survival.
10A 34-year-old G2P1 woman at 26 weeks of gestation undergoes a standard 75 g oral glucose tolerance test (OGTT) for gestational diabetes mellitus (GDM) screening. The plasma glucose results are: Fasting 5.4 mmol/L (97 mg/dL), 1-hour 10.4 mmol/L (187 mg/dL), and 2-hour 8.2 mmol/L (148 mg/dL). According to SGGG and IADPSG diagnostic criteria, what is the interpretation and the recommended initial management?
A.Normal glucose tolerance test; routine obstetric follow-up with no dietary changes
B.Impaired fasting glucose only; repeat the 75 g OGTT at 32 weeks of gestation
C.Overt pregestational diabetes; initiate high-dose basal-bolus insulin therapy immediately without lifestyle intervention
D.Gestational diabetes mellitus (GDM); initiate medical nutritional therapy, moderate physical activity, and blood glucose self-monitoring as first-line therapy
Explanation: Under the IADPSG and SGGG criteria, GDM is diagnosed if any ONE plasma glucose value meets or exceeds the thresholds: Fasting ≥5.1 mmol/L, 1-hour ≥10.0 mmol/L, or 2-hour ≥8.5 mmol/L. This patient meets criteria on both fasting (5.4) and 1-hour (10.4) values. First-line management is medical nutritional therapy, lifestyle modification, and daily self-monitoring of blood glucose (fasting target <5.3 mmol/L, 1h postprandial <8.0 mmol/L or 2h postprandial <7.0 mmol/L). Insulin is initiated if glycemic targets are not met after 1–2 weeks.

About the Facharzt FMH Gynäkologie und Geburtshilfe Exam

The Facharzt FMH für Gynäkologie und Geburtshilfe (Specialist in Obstetrics and Gynaecology FMH) is the Swiss Federal postgraduate specialist title granting full independent practice rights in obstetrics and gynecology across Switzerland. Governed by the SIWF (Swiss Institute for Postgraduate and Continuous Medical Training) and the SGGG (Swiss Society of Obstetrics and Gynaecology / SSGO), qualification requires completing at least 5 years of accredited postgraduate residency training, passing the 120-question written multiple-choice examination, passing the oral-practical board examination, and fulfilling all surgical and clinical e-Logbook requirements. The core curriculum spans maternal-fetal medicine, high-risk obstetrics, intrapartum care, obstetric emergencies, benign and operative gynecology, gynecologic oncology, senology/breast disease, reproductive endocrinology and infertility, and urogynecology. Note on format and language: While the official Swiss examination is administered in German and French (using the EGONE e-learning platform and SGGG Expertenbriefe as core reference material), this question bank is an English-language multiple-choice study adaptation created by OpenExamPrep—not an official SGGG examination release—specifically designed to train high-yield clinical decision-making, surgical anatomy, and evidence-based protocols.

Assessment

Two-part qualifying assessment: 1) Written Multiple-Choice Examination (Basisexamen / Schlussexamen Teil 1) comprising 120 MCQs (4 hours) testing the comprehensive curriculum based on EGONE and clinical guidelines; 2) Oral-practical examination (Schlussexamen Teil 2, 60–90 minutes) consisting of case presentations, operative intervention analysis, and structured clinical stations before a panel of expert examiners.

Time Limit

240 minutes written examination plus approximately 60–90 minutes structured oral-practical examination

Passing Score

Criterion-referenced passing score on the 120-MCQ written examination and structured consensus passing evaluation across all clinical case stations and surgical logbook discussions in the oral-practical examination

Exam Fee

Written MCQ Exam CHF 600; Oral-Practical Exam CHF 2,500; SIWF FMH Title Application fee CHF 1,000–2,500 (Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe (SGGG / SSGO) & Schweizerisches Institut für ärztliche Weiter- und Fortbildung (SIWF / FMH))

Facharzt FMH Gynäkologie und Geburtshilfe Exam Content Outline

35%

Obstetrics & Perinatal Medicine (Geburtshilfe & Perinatologie)

Antenatal screening, ultrasound, preeclampsia/HELLP, fetal growth restriction (Doppler flows), preterm labor, labor induction, intrapartum CTG monitoring, operative vaginal delivery, postpartum hemorrhage (PPH), obstetric emergencies, and puerperal care.

25%

General & Operative Gynecology (Allgemeine & Operative Gynäkologie)

Benign uterine disorders (leiomyomas, adenomyosis, AUB), endometriosis (#Enzian classification), acute pelvic pain, pelvic inflammatory disease, ectopic pregnancy, laparoscopy and hysteroscopy safety, surgical complications, and benign vulvovaginal disorders.

20%

Gynecologic Oncology & Senology (Gynäkologische Onkologie & Senologie)

Cervical cancer (HPV screening, Bethesda, FIGO staging, trachelectomy, chemoradiation), endometrial cancer (FIGO 2023 molecular classification, sentinel node), ovarian cancer (cytoreduction, PARP inhibitors), vulvar cancer, gestational trophoblastic disease, and breast cancer diagnosis/multimodality therapy.

12%

Reproductive Endocrinology, Infertility & Contraception

Menstrual cycle physiology, PCOS (Rotterdam criteria, letrozole), amenorrhea workup, menopausal hormone therapy (MHT), hormonal and non-hormonal contraception (WHO MEC), emergency contraception, infertility workup, and assisted reproductive technologies (ART/OHSS).

8%

Urogynecology & Pelvic Floor Disorders (Urogynäkologie)

Pelvic organ prolapse (POP-Q staging, pessaries, surgical repairs), stress and urge urinary incontinence, urodynamic testing, recurrent urinary tract infections, and obstetric/iatrogenic fistulas.

How to Pass the Facharzt FMH Gynäkologie und Geburtshilfe Exam

What You Need to Know

  • Passing score: Criterion-referenced passing score on the 120-MCQ written examination and structured consensus passing evaluation across all clinical case stations and surgical logbook discussions in the oral-practical examination
  • Assessment: Two-part qualifying assessment: 1) Written Multiple-Choice Examination (Basisexamen / Schlussexamen Teil 1) comprising 120 MCQs (4 hours) testing the comprehensive curriculum based on EGONE and clinical guidelines; 2) Oral-practical examination (Schlussexamen Teil 2, 60–90 minutes) consisting of case presentations, operative intervention analysis, and structured clinical stations before a panel of expert examiners.
  • Time limit: 240 minutes written examination plus approximately 60–90 minutes structured oral-practical examination
  • Exam fee: Written MCQ Exam CHF 600; Oral-Practical Exam CHF 2,500; SIWF FMH Title Application fee CHF 1,000–2,500

Keys to Passing

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Facharzt FMH Gynäkologie und Geburtshilfe Study Tips from Top Performers

1Master CTG Interpretation & FIGO 2015 Criteria: Be proficient in categorizing intrapartum cardiotocography into normal, suspicious, and pathological, understanding decelerations (early, variable, late, prolonged), baseline variability, and indications for fetal scalp blood sampling or immediate delivery.
2Review FIGO 2023 Endometrial Cancer Molecular Subtypes: Understand the four prognostic categories (POLE ultramutated, MMRd/MSI-H, p53abn, and NSMP) and how molecular classification directs the need for adjuvant radiotherapy and systemic chemotherapy.
3Memorize Postpartum Hemorrhage Escalation Protocols: Know the step-by-step management of PPH from prophylactic oxytocin to second-line uterotonics (sulprostone/carboprost/misoprostol), tranexamic acid within 3 hours, intrauterine balloon tamponade (Bakri), and surgical options (B-Lynch suture, uterine artery ligation, hysterectomy).
4Understand Fetal Growth Restriction Doppler Criteria: Know the surveillance intervals and delivery triggers for early- vs late-onset FGR based on umbilical artery Doppler (positive, absent, or reversed end-diastolic velocity), ductus venosus pulsatility index, and computerized CTG short-term variability (STV).
5Master Contraception WHO MEC Criteria: Memorize Category 4 (absolute contraindications) for combined hormonal contraceptives, including migraine with aura, hypertension ≥160/100, smoking age ≥35 with ≥15 cigarettes/day, and history of venous thromboembolism.

Frequently Asked Questions

What is the Facharzt FMH für Gynäkologie und Geburtshilfe title?

The Facharzt FMH für Gynäkologie und Geburtshilfe is the federally recognized medical specialist title awarded by the SIWF / FMH (Swiss Medical Association) upon completion of at least 5 years of accredited postgraduate clinical training, passing both the written and oral-practical SGGG board examinations, and meeting all surgical logbook requirements.

How is the Swiss OB/GYN specialist examination structured?

The examination consists of two main parts: 1) A written 120-question multiple-choice examination (Basisexamen or Schlussexamen Teil 1) taking 4 hours; 2) An oral-practical examination (Schlussexamen Teil 2) lasting 60–90 minutes involving clinical case presentations (1 obstetric and 1 gynecologic case), surgical logbook discussion, and structured oral clinical questions.

What is the difference between the Basisexamen and Schlussexamen Teil 1?

The Basisexamen and the written part of the Schlussexamen use the same 120-question examination booklet administered on the same examination date. However, the passing standard is lower for the Basisexamen (taken earlier during residency) and higher for the Schlussexamen (required for the final specialist title).

What primary learning resources and guidelines are recommended?

The official learning platform recommended by the Swiss Chief Physicians Conference is EGONE (e-learning in Gynaecology and Obstetrics). Candidates are also expected to master the SGGG Expertenbriefe (expert letters), joint DGGG-SGGG-OeGGG S3 guidelines, and FIGO/ESGO/ESHRE consensus standards.

Why is this practice bank presented in English?

While the official Swiss examination is administered in German and French, modern gynecological oncology, perinatology, and reproductive endocrinology clinical trial data and international guidelines (FIGO, ESGO, ESHRE, ISUOG) are universally published in English. This practice bank adapts Swiss and international curriculum standards into 100 high-yield English-language questions.

What are the common obstetric emergencies tested on the Swiss board?

High-yield emergencies include postpartum hemorrhage (4Ts algorithm, uterotonics, balloon tamponade, and surgical techniques), shoulder dystocia (HELPERR mnemonic), eclampsia and magnesium sulfate protocols, umbilical cord prolapse, amniotic fluid embolism, and uterine rupture during trial of labor after cesarean (TOLAC).